Men with a history of prostate cancer may be at increased risk for melanoma, according to data taken from two large cohort studies.


Men who used sildenafil (Viagra) had an 84% increased risk for developing melanoma, even after adjusting for known risk factors, according to the results of a prospective study.

Living alone increased a man’s risk for being diagnosed with later stage melanoma by more than 40%, according to the results of a recent Swedish study.

Advanced melanoma patients treated with the anti–PD-1 inhibitor MK-3475 with tumors that expressed PD-L1 had higher survival rates and more robust immune responses compared with patients with tumors that did not express PD-L1.

At the 1-day Cancer Immunotherapy: A Long Awaited Reality Conference, representatives from biotechnology companies and research clinicians working on immunotherapies discussed the promise of combination immunotherapies in cancer.

In a recent study, survivors of either an invasive or in situ melanoma had about five times the risk for a second primary melanoma compared with the general population.

Nonsentinel lymph node status in melanoma patients who underwent complete lymph node dissection after positive sentinel lymph node biopsy had independent prognostic value.

As the incidence of malignant melanoma continues to rise, so does primary care physicians’ need to identify pigmented lesions for early detection. Take a look at these presentations to test your knowledge.


Subscribe to
Please Wait 20 seconds or click here to close